Amgen Archives - Pharmaphorum

Concerns over Teva migraine drug because of manufacturing issues

https://pharmaphorum.com/news/concerns-over-teva-migraine-drug-because-of-manufacturing-issues/

FDA approves second Neupogen biosimilar

https://pharmaphorum.com/news/fda-approves-second-neupogen-biosimilar/

Amgen and UCB re-file Evenity for US approval

https://pharmaphorum.com/news/amgen-ucb-evenity-fda-filing/

Lilly joins CGRP race to cure migraine

https://pharmaphorum.com/news/lilly-joins-cgrp-race-to-cure-migraine/

https://pharmaphorum.com/news/mylan-to-market-lupins-enbrel-biosimilar-outside-us/

Alexion hastens review of successor to rare disease blockbuster Soliris

https://pharmaphorum.com/news/alexion-hastens-review-of-successor-to-rare-disease-blockbuster-soliris/

Amgen’s blood cancer drug gets full EU licence

https://pharmaphorum.com/news/amgens-blood-cancer-drug-blincyto-licence/

Top pharmaceutical companies in the world in 2017

https://pharmaphorum.com/views-and-analysis/top-pharmaceutical-companies-world-2017/

Amgen’s Repatha gets EU cardio risk reduction label

https://pharmaphorum.com/news/amgens-repatha-gets-eu-cardio-risk-reduction-label/

Search